yeahright
Well-known member
FDA orders supplements seized
United Press International
09-08-06
FORT WALTON BEACH, Fla., Sep 7, 2006 (UPI via COMTEX) -- U.S. marshals have seized $55,000 worth of dietary supplements produced by Advantage Nutraceuticals LLC of Fort Walton Beach, Fla.
The U.S. Food and Drug Administration said it ordered the EllagiMax capsules, Coral Max capsules, Coral Max without Iron capsule, and Advanced Arthritis Support capsules be seized after alleging the products violate a new drug and misbranding provisions of the Federal Food, Drug and Cosmetic Act.
The FDA said the products are labeled as "dietary supplements," but the products' labeling, promotional literature, an audio cassette tape and two Web sites make claims typically associated with drug products. The capsules claim to benefit patients with cancer, arthritis, fibromyalgia, seizures and other conditions, the FDA said.
The labeling caused the FDA to classify the products as unapproved new drugs, which must be approved by the administration before it can be marked to the public.
The FDA has advised patients taking the capsules to consult with their doctors.
United Press International
09-08-06
FORT WALTON BEACH, Fla., Sep 7, 2006 (UPI via COMTEX) -- U.S. marshals have seized $55,000 worth of dietary supplements produced by Advantage Nutraceuticals LLC of Fort Walton Beach, Fla.
The U.S. Food and Drug Administration said it ordered the EllagiMax capsules, Coral Max capsules, Coral Max without Iron capsule, and Advanced Arthritis Support capsules be seized after alleging the products violate a new drug and misbranding provisions of the Federal Food, Drug and Cosmetic Act.
The FDA said the products are labeled as "dietary supplements," but the products' labeling, promotional literature, an audio cassette tape and two Web sites make claims typically associated with drug products. The capsules claim to benefit patients with cancer, arthritis, fibromyalgia, seizures and other conditions, the FDA said.
The labeling caused the FDA to classify the products as unapproved new drugs, which must be approved by the administration before it can be marked to the public.
The FDA has advised patients taking the capsules to consult with their doctors.